Durvalumab Consolidation After Chemoradiation Therapy for Limited Stage SCLC in China

The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer

NCT06287320 ·Status: RECRUITING

A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC

NCT06443684 ·Status: RECRUITING

Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer

NCT07035860 ·Status: NOT_YET_RECRUITING

Multicenter Observational Study of Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Rare Driver Gene Mutation

NCT04137718 ·Status: UNKNOWN

Efficacy and Safety of Durvalumab in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis

NCT04356222 ·Status: UNKNOWN ·Phase: PHASE4

A Study of the Correlation Between CRF, Survival and Physiological Factors in NSCLC Patients Under Chemotherapy

NCT03130192 ·Status: UNKNOWN

Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy

NCT06869239 ·Status: RECRUITING

MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC

NCT06198868 ·Status: RECRUITING

Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers

NCT04712877 ·Status: RECRUITING

Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and Outcomes

NCT07215026 ·Status: COMPLETED

68Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLC

NCT06756217 ·Status: RECRUITING

Prospective Evaluation of Immunological, Molecular-genetic, Image-based and Microbial Analyzes to Characterize Tumor Response and Control in Patients With Inoperable Stage III NSCLC Treated With Chemoradiotherapy Followed by Consolidation Therapy With Durvalumab

NCT05027165 ·Status: UNKNOWN

Study of Blood, Tumor and Adjacent Normal Tissue Samples From Chinese Smoking Induced Lung Cancer Patients

NCT02113852 ·Status: COMPLETED

Adjuvant Chemotherapy for High-Risk Pathologic Stage I Non-Squamous NSCLC

NCT07250360 ·Status: COMPLETED

Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy

NCT07256002 ·Status: ACTIVE_NOT_RECRUITING

Clinical Study on the Prevention of Driver Gene Negative Ib-IIIb Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors

NCT05834413 ·Status: RECRUITING ·Phase: NA

A Prospective Randomized Study Comparing the Target Volume for Limited-stage Small Cell Lung Cancer

NCT01731548 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Precision Diagnosis and Therapy for Early Stage Lung Cancer

NCT02936804 ·Status: UNKNOWN ·Phase: NA

Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer

NCT02202655 ·Status: UNKNOWN

Cardiac Substructure Radiation Dose and Early Clinical Monitoring of Stage N2-3 Non-Small Cell Lung Cancer

NCT05252065 ·Status: UNKNOWN

Efficacy and Safety of Cryoablation with Robotic Bronchoscopy System in Patients with Lung Cancer

NCT06832956 ·Status: NOT_YET_RECRUITING ·Phase: NA

Proton Therapy to Reduce Acute Normal Tissue Toxicity in Locally Advanced Non-small-cell Lung Cancer

NCT02731001 ·Status: RECRUITING ·Phase: NA

PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers

NCT00136890 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Camrelizumab in Real-World Prospective Study

NCT04793139 ·Status: UNKNOWN

Liquid Biopsy for Detection of Driver Mutation in NSCLC

NCT02778854 ·Status: UNKNOWN